Multi-Regional Compliance Engine

DNXT Publisher Suite — Compliance Engine

One Dossier.
Five Regions.
Zero Rework.

DNXT's Multi-Regional Compliance Engine maintains a single canonical dossier and generates fully compliant submission packages for US FDA, ICH, Health Canada, SAHPRA, and GCC — simultaneously. Regional TOC templates, Module 1 document sets, and metadata schemas are built into the platform, not bolted on by your team.

🗂
Canonical Source
Dossier Core
Modules 1–5 · Unified
🇺🇸 US FDA ✓ Compliant
🌐 ICH ✓ Compliant
🇨🇦 Health Canada ✓ Compliant
🇿🇦 SAHPRA ✓ Compliant
🌙 GCC ✓ Compliant
Auto-generated · Region-specific TOC · M1 · Metadata · Validation
5 Regulatory Regions
Supported Natively
1 Canonical Source
Dossier to Maintain
Zero Manual Rework When
Core Documents Change
100% Regional Spec Coverage
Built Into Platform

Who This Is Built For

Built for regulatory operations professionals who have spent years maintaining parallel submission copies across regions and know exactly how much that costs in time, errors, and delayed approvals.

Global Regulatory Affairs
VP, Global Regulatory Operations
Mid-size pharma · 3–6 active global programs

Your teams in Boston, London, and Singapore each maintain their own copy of the dossier for their region. Every time a clinical study report is revised, you spend two days coordinating who has updated which regional copy, running version checks, and QC'ing that the updated document appears correctly in every regional TOC. One missed update in Module 3 cost you a 90-day FDA deficiency letter last cycle. The parallel track problem isn't a people problem — it's a structural one.

  • Single source of truth eliminates cross-regional version drift permanently
  • Document updates propagate instantly across all five regional packages without manual intervention
  • Centralized regulatory team can manage all regions — no need for siloed regional publishing teams
  • Regional TOC discrepancies caught at the platform layer before submission, not by the agency
CRO Regulatory Publishing
Director, Regulatory Publishing
Full-service CRO · 15–40 concurrent client submissions

You're managing multi-regional submissions for eight clients simultaneously, and each one has a different configuration of regions. Your publishing team spends 30–40% of their time on the mechanical work of reformatting Module 1 document sets, adjusting metadata fields for each region, and restructuring TOCs to match regional specs — work that adds no scientific value and that clients are increasingly unwilling to pay for at legacy rates. When a client changes a document on a Friday, your team works the weekend to keep five regional packages synchronized.

  • Regional package generation becomes a platform operation, not a billable labor task
  • Onboard new clients' multi-regional programs in hours, not days of configuration work
  • Eliminates weekend fire drills when source documents change close to submission deadlines
  • Consistent validation output across all client submissions reduces QC overhead by project
Biotech Leadership
Chief Development Officer / Head of Regulatory
Biotech · First global IND or NDA/MAA submission

You're a lean team preparing your first simultaneous multi-regional submission and you don't have the institutional knowledge to know what Health Canada's CA22 Module 1 requires versus what the GCC expects. Your regulatory consultant is expensive and you're burning time on specification research rather than on strategy. You've been told by your CRO that building a simultaneous FDA + EMA + Health Canada submission in parallel will take three times the resources of a sequential submission — which means a sequential strategy that delays your go-to-market by 18 months.

  • Regional specifications are baked into the platform — no need to research agency-by-agency requirements from scratch
  • Simultaneous multi-regional submission becomes feasible for a team of 3, not 15
  • Compress sequential 18-month regional rollout into a single parallel submission event
  • Gain competitive time-to-market in all five regions rather than region-by-region

How It Works

From a single authored dossier to five agency-ready submission packages — here is what the compliance engine does at each stage, and why it matters for the integrity of your submission.

1
Ingestion
Canonical Dossier Import & Structural Indexing

When documents are uploaded or authored within DNXT, the platform ingests them into a structured dossier object — not as flat files in a folder, but as typed nodes in a graph-like dossier model. Each document is identified by its eCTD section reference (e.g., m2.7.4, m5.3.5.1), its document type, lifecycle state, and content hash. This canonical index is the single authoritative record from which all regional variants are derived. Nothing downstream touches source files directly — every operation is a read from this indexed model.

2
Region Selection
Region Scope Declaration — Not Configuration

The user declares which regions are in scope for a submission event — for example, US FDA + Health Canada + GCC. This declaration triggers the compliance engine to load the pre-built regional specification profiles for each selected region. Critically, these specification profiles — TOC template, Module 1 document requirements, required metadata fields, validation rule sets, and sequence numbering conventions — are maintained by DNXT and versioned against each agency's published technical standards. There is no manual configuration by the customer. Selecting "Health Canada" means the CA22 eCTD specification is applied automatically, including its unique Module 1.2 regional administrative information requirements.

3
TOC Rendering
Regional TOC Generation from Canonical Document Map

The engine resolves the canonical dossier index against each regional TOC template and generates region-specific table of contents structures. For regions like ICH, this follows the standard eCTD module hierarchy. For Health Canada, the engine applies the CA22-specific TOC including the regional Module 1 envelope. For SAHPRA and GCC, which have their own Module 1 structures and section ordering conventions, the engine applies those templates without the user needing to understand the underlying difference. Each generated TOC is expressed in the region's required XML format — leaf.xml, backbone files, or eCTD envelope files — and is validated against the region's published schema before it is ever presented to the user.

4
Module 1 Assembly
Region-Specific Module 1 Document Set Populated & Validated

Module 1 is the most variable part of any multi-regional submission — what FDA requires in section 1.2 is different from what Health Canada expects in its administrative information package, which differs again from SAHPRA's cover letter and CTD-specific cover page requirements. DNXT maintains a Module 1 document schema for each region that specifies exactly which documents are required, which are optional, what the accepted file formats are, and what the metadata must contain. The engine identifies which Module 1 documents the user has provided, maps them to region-specific slots, and flags any gaps before the submission is packaged. Document authoring templates for region-specific Module 1 forms (e.g., FDA Form 356h, Health Canada HC/SC 3011) are included in the platform.

5
Metadata Encoding
Per-Region Metadata Schema Applied & Embedded

Each region requires metadata to be encoded differently in the submission XML — field names, controlled vocabulary values, date formats, and required attributes vary across agencies. The compliance engine applies each region's metadata schema to the canonical document index and generates the correct metadata output for each regional package. For FDA submissions, this means conformance with the FDA eCTD specification and CDER/CBER metadata requirements. For Health Canada, the CA22 metadata schema with its specific product and company identifier conventions. For GCC, the Gulf Central Committee's eCTD metadata requirements are applied. Metadata is never manually transcribed — it flows from the canonical dossier object through the regional schema filter and into the submission package automatically.

6
Lifecycle Enforcement
Region-Specific Lifecycle Rules Applied Before Packaging

Lifecycle operations — new, replace, append, delete — have different rules per region. FDA eCTD has specific rules about when a replace operation is valid versus when a delete-and-new sequence is required. Health Canada has its own lifecycle guidance that diverges in edge cases. The compliance engine enforces these rules at the operation layer: if a user attempts an operation that is invalid under a region's lifecycle rules, the system blocks the operation and explains why. This means lifecycle errors are caught before packaging, not discovered during agency technical screening — which is typically the most costly point to discover them, often triggering a reject and resubmit cycle that delays review by weeks or months.

7
Package Delivery
Validated Regional Packages Exported for Submission

The final output is five independently validated, agency-ready submission packages — each with its own correct folder structure, file naming conventions, backbone XML, leaf XML, Module 1 documents, and metadata. Each package passes an automated pre-submission validation run against the region's published validation criteria (e.g., FDA ECTD Validation Criteria version 6.1, Health Canada CA22 technical specifications) before being made available for download or direct gateway submission. A submission readiness report is generated for each region showing validation pass/fail status, rule coverage, and any advisory warnings. All five packages are generated from the same canonical source and are guaranteed internally consistent — if a document is version 3.1 in the FDA package, it is version 3.1 in every other regional package.

What the Engine Does

Six core capabilities that transform multi-regional publishing from a parallelized manual effort into a single, centrally managed platform operation.

🇺🇸

US FDA Publishing

DNXT generates FDA eCTD submission packages conforming to the current FDA eCTD Validation Criteria specification, including correct backbone XML structure, leaf file generation, and sequence numbering. Module 1 assembly includes FDA Form 356h, cover letter, and regulatory information section handling. The platform enforces FDA-specific lifecycle operation rules — for example, blocking a replace operation where the prior sequence used a delete, which FDA's CDER reviewers routinely flag. Validation output maps directly to FDA's published technical rejection criteria, so teams can resolve issues before submission rather than after a technical screening failure.

🌐

ICH eCTD Publishing

The ICH eCTD specification underpins submissions to EMA, TGA, PMDA, and other ICH-aligned agencies. DNXT's ICH publishing module implements the full ICH eCTD implementation guide including correct module hierarchy, XML instance conformance, and the ICH granularity rules that determine when documents should be split or combined across sections. Because ICH serves as the base standard for multiple agencies, the ICH package generated by DNXT can be used directly as the core technical package for submissions where a regional Module 1 envelope is applied on top — eliminating the need to rebuild the technical dossier for each ICH-aligned market.

🇨🇦

Health Canada CA22 Publishing

Health Canada's CA22 eCTD specification diverges from ICH in several important ways — most significantly in its Module 1 structure, which includes specific regional administrative information sections, Drug Identification Number handling, and product monograph requirements that have no direct ICH equivalent. DNXT's Health Canada module applies the CA22 XML schema, generates the correct Health Canada-specific envelope structure, and handles the Module 1.2 regional administrative information package including the HC/SC 3011 administrative information form. Metadata encoding follows Health Canada's required product and submission identifier conventions, and lifecycle operations are validated against Health Canada's published eCTD lifecycle guidance.

🇿🇦

South Africa SAHPRA Publishing

SAHPRA accepts eCTD submissions and has its own Module 1 requirements and administrative document set that differs from both FDA and ICH practice. DNXT's SAHPRA module handles the SAHPRA-specific CTD cover page, section 1.2 regional administrative information, and the particular formatting requirements that SAHPRA's technical screening team applies. For companies expanding into African markets — increasingly a priority for generics manufacturers and innovator companies targeting Sub-Saharan access programs — having SAHPRA support natively integrated alongside the other four regions means African market submissions are a first-class output, not an afterthought adaptation.

🌙

GCC Gulf Region Publishing

The Gulf Central Committee (GCC) eCTD specification governs submissions to Saudi Arabia, UAE, Kuwait, Bahrain, Oman, and Qatar through the GULF MARK mutual recognition pathway. The GCC has specific Module 1 requirements, metadata conventions, and technical submission requirements that are distinct from ICH and FDA. DNXT's GCC module generates submission packages conforming to the GCC eCTD technical specification, including the GCC-specific product information summary and administrative document requirements. For pharma companies with commercial operations in the Gulf region, having GCC as a native output alongside FDA and ICH packages enables true simultaneous global launch strategies rather than sequential regional rollouts.

⚙️

Auto-Applied Regional Rules Engine

The rules engine is the technical core of the compliance engine — it is what makes "select a region and get a compliant package" possible without customer-side configuration. Regional rule sets encode each agency's validation criteria, lifecycle operation rules, metadata requirements, and structural requirements as machine-executable logic. When a region is selected, its complete rule set is activated. When a document is added, modified, or a lifecycle operation is attempted, the rules engine evaluates the action against all active regional rule sets in parallel and surfaces any conflicts, violations, or warnings in real time — before they are baked into a package. Rule sets are maintained and updated by DNXT's regulatory team as agencies publish specification updates, so customers are always running against current agency requirements without needing to track specification changes themselves.

DNXT vs. The Alternative

Every platform claims to support multi-regional submissions. Here is what that actually means in practice — and where legacy tools leave your regulatory team doing the work the software should do.

Capability DNXT Publisher Suite Veeva Vault RIM EXTEDO eCTDmanager LORENZ docuBridge
Regional Spec Storage Built into platform — zero customer config required Vault stores documents; regional specs must be configured and maintained by the customer's admin team Partial — some region templates available but require version-specific manual updates Supports eCTD publishing but regional M1 templates require manual setup per project
Single Source → Multiple Regions One canonical dossier, all five regional packages generated on demand Vault manages document records but generating region-specific submission packages requires separate workflows per region — regional teams typically maintain parallel submission sequences Per-submission projects are configured independently; document synchronization across regional projects is a manual process docuBridge processes one submission at a time; multi-regional parallelism is an organizational workflow, not a